| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.054 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |